INHIBITION OF MYRICETIN ON HUMAN LUNG ADENOCARCINOMA H460 CELL PROLIFERATION AND THE ROLE OF ERK PATHWAY

ZHANG Xiao-hong,XU Chen-wei,ZOU Zu-quan,GONG Qing-hai,ZHUO Ren-jie,LI Duo
DOI: https://doi.org/10.13325/j.cnki.acta.nutr.sin.2010.03.027
2010-01-01
Abstract:Objective To investigate the effects of myricetin on the H460 lung adenocarcinoma cell proliferation and clarify the underlying mechanism.Method The inhibitory effects of myricetin on the growth of H460 cells were investigated and its value of IC50 after 72 h incubation were measured by monotetrazolium(MTT) method.The levels of pAkt (phosphorylated protein kinase B)Ser473,PERK (phosphorylated extracellular signal-regulated kinase)1/2,cyclin D1,total Akt and ERK1/2 proteins were detected by Western blotting.The cell cycle was investigated by flow cytometry.Results Myricetin inbibited the H460 cell proliferation in a dose-dependent way.The IC50 of myricetin treatment for 72 h was 60μg/ml.Myricetin treatment remarkably reduced the percentage of cells in G2/M phase.It was found that myricetin remarkbly reduced the phosphorylation of ERK1/2,and cyclin D1 protein level,but did not influence the level of phospholated AktSer473.Conclusion Myricetin could inhibit the growth of H460 cell in a dose-dependent way,inhibite the G2/M progression.ERK-Cyclin D1 pathway may play an important role in regulation of cell cycle in H460 by myricein.
What problem does this paper attempt to address?